Home
>
National Drug Code (NDC)
>
Pyrazinamide
Pyrazinamide - 67253-660-50 - (Pyrazinamide)
Drug Information of Pyrazinamide
| Product NDC: | 67253-660 |
| Proprietary Name: | Pyrazinamide |
| Non Proprietary Name: | Pyrazinamide |
| Active Ingredient(s): | 500 mg/1 & nbsp; Pyrazinamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pyrazinamide
| Product NDC: | 67253-660 |
| Labeler Name: | DAVA Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA080157 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19710603 |
Package Information of Pyrazinamide
| Package NDC: | 67253-660-50 |
| Package Description: | 500 TABLET in 1 BOTTLE (67253-660-50) |
NDC Information of Pyrazinamide
| NDC Code | 67253-660-50 |
| Proprietary Name | Pyrazinamide |
| Package Description | 500 TABLET in 1 BOTTLE (67253-660-50) |
| Product NDC | 67253-660 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pyrazinamide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19710603 |
| Marketing Category Name | ANDA |
| Labeler Name | DAVA Pharmaceuticals, Inc. |
| Substance Name | PYRAZINAMIDE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antimycobacterial [EPC] |
